BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lieberthal W, Levine JS. Mammalian target of rapamycin and the kidney. II. Pathophysiology and therapeutic implications. Am J Physiol Renal Physiol 2012;303:F180-91. [PMID: 22496407 DOI: 10.1152/ajprenal.00015.2012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Abou Daher A, Alkhansa S, Azar WS, Rafeh R, Ghadieh HE, Eid AA. Translational Aspects of the Mammalian Target of Rapamycin Complexes in Diabetic Nephropathy. Antioxid Redox Signal 2021. [PMID: 34544257 DOI: 10.1089/ars.2021.0217] [Reference Citation Analysis]
2 Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature. 2013;493:338-345. [PMID: 23325216 DOI: 10.1038/nature11861] [Cited by in Crossref: 969] [Cited by in F6Publishing: 891] [Article Influence: 107.7] [Reference Citation Analysis]
3 Thévenod F, Lee WK. Live and Let Die: Roles of Autophagy in Cadmium Nephrotoxicity. Toxics 2015;3:130-51. [PMID: 29056654 DOI: 10.3390/toxics3020130] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
4 Xu JX, Lu TS, Li S, Wu Y, Ding L, Denker BM, Bonventre JV, Kong T. Polycystin-1 and Gα12 regulate the cleavage of E-cadherin in kidney epithelial cells. Physiol Genomics 2015;47:24-32. [PMID: 25492927 DOI: 10.1152/physiolgenomics.00090.2014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
5 Stames EM, O'Toole JF. Mitochondrial aminopeptidase deletion increases chronological lifespan and oxidative stress resistance while decreasing respiratory metabolism in S. cerevisiae. PLoS One 2013;8:e77234. [PMID: 24116217 DOI: 10.1371/journal.pone.0077234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
6 Cheng H, Fan X, Lawson WE, Paueksakon P, Harris RC. Telomerase deficiency delays renal recovery in mice after ischemia-reperfusion injury by impairing autophagy. Kidney Int 2015;88:85-94. [PMID: 25760322 DOI: 10.1038/ki.2015.69] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
7 Mekahli D, Parys JB, Bultynck G, Missiaen L, De Smedt H. Polycystins and cellular Ca2+ signaling. Cell Mol Life Sci 2013;70:2697-712. [PMID: 23076254 DOI: 10.1007/s00018-012-1188-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
8 Jiang L, Xu L, Mao J, Li J, Fang L, Zhou Y, Liu W, He W, Zhao AZ, Yang J, Dai C. Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis. J Am Soc Nephrol 2013;24:1114-26. [PMID: 23661807 DOI: 10.1681/ASN.2012050476] [Cited by in Crossref: 51] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
9 Wang S, Dong Z. Primary cilia and kidney injury: current research status and future perspectives. Am J Physiol Renal Physiol 2013;305:F1085-98. [PMID: 23904226 DOI: 10.1152/ajprenal.00399.2013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
10 Soliman A, Zamil S, Lotfy A, Ismail E. Sirolimus Produced S-Shaped Effect on Adult Polycystic Kidneys After 2-Year Treatment. Transplantation Proceedings 2012;44:2936-9. [DOI: 10.1016/j.transproceed.2012.06.073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
11 Sivertsson E, Friederich-Persson M, Öberg CM, Fasching A, Hansell P, Rippe B, Palm F. Inhibition of mammalian target of rapamycin decreases intrarenal oxygen availability and alters glomerular permeability. Am J Physiol Renal Physiol 2018;314:F864-72. [PMID: 28971989 DOI: 10.1152/ajprenal.00033.2017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol 2016;12:325-38. [PMID: 27108839 DOI: 10.1038/nrneph.2016.48] [Cited by in Crossref: 1060] [Cited by in F6Publishing: 1073] [Article Influence: 176.7] [Reference Citation Analysis]
13 Lovisa S, Zeisberg M, Kalluri R. Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis. Trends Endocrinol Metab 2016;27:681-95. [PMID: 27372267 DOI: 10.1016/j.tem.2016.06.004] [Cited by in Crossref: 98] [Cited by in F6Publishing: 97] [Article Influence: 16.3] [Reference Citation Analysis]
14 Cunard R. Mammalian tribbles homologs at the crossroads of endoplasmic reticulum stress and Mammalian target of rapamycin pathways. Scientifica (Cairo) 2013;2013:750871. [PMID: 24490110 DOI: 10.1155/2013/750871] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
15 Ferreira A, Felipe C, Cristelli M, Viana L, Basso G, Stopa S, Mansur J, Ivani M, Bessa A, Ruppel P, Aguiar W, Campos E, Gerbase-delima M, Proença H, Tedesco-silva H, Medina-pestana J. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus. Am J Nephrol 2017;45:497-508. [DOI: 10.1159/000475888] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
16 Li A, Fan S, Xu Y, Meng J, Shen X, Mao J, Zhang L, Zhang X, Moeckel G, Wu D, Wu G, Liang C. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis. J Cell Mol Med 2017;21:1619-35. [PMID: 28244683 DOI: 10.1111/jcmm.13091] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
17 Duan Y, Zhang D, Ye Y, Zheng S, Huang P, Zhang F, Mo G, Huang F, Yin Q, Li J, Han L. Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome. Front Pharmacol 2021;12:765563. [PMID: 34938183 DOI: 10.3389/fphar.2021.765563] [Reference Citation Analysis]
18 Axelsson J, Rippe A, Rippe B. mTOR inhibition with temsirolimus causes acute increases in glomerular permeability, but inhibits the dynamic permeability actions of puromycin aminonucleoside. Am J Physiol Renal Physiol 2015;308:F1056-64. [PMID: 25740597 DOI: 10.1152/ajprenal.00632.2014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
19 Braun WE, Schold JD, Stephany BR, Spirko RA, Herts BR. Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study. Clin J Am Soc Nephrol. 2014;9:881-888. [PMID: 24721888 DOI: 10.2215/cjn.02650313] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
20 Soltani A, Bahreyni A, Boroumand N, Roshan MK, Khazaei M, Ryzhikov M, Soleimanpour S, Avan A, Hassanian SM. Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives. J Cell Physiol 2018;233:4783-90. [PMID: 29165795 DOI: 10.1002/jcp.26276] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
21 Zhenyukh O, Civantos E, Ruiz-Ortega M, Sánchez MS, Vázquez C, Peiró C, Egido J, Mas S. High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation. Free Radic Biol Med 2017;104:165-77. [PMID: 28089725 DOI: 10.1016/j.freeradbiomed.2017.01.009] [Cited by in Crossref: 123] [Cited by in F6Publishing: 119] [Article Influence: 24.6] [Reference Citation Analysis]
22 Wu Y, Xu JX, El-Jouni W, Lu T, Li S, Wang Q, Tran M, Yu W, Wu M, Barrera IE, Bonventre JV, Zhou J, Denker BM, Kong T. Gα12 is required for renal cystogenesis induced by Pkd1 inactivation. J Cell Sci 2016;129:3675-84. [PMID: 27505895 DOI: 10.1242/jcs.190496] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
23 Klen J, Goričar K, Horvat S, Stojan J, Dolžan V. DEPTOR polymorphisms influence late complications in Type 2 diabetes patients. Pharmacogenomics 2019;20:879-90. [PMID: 31453770 DOI: 10.2217/pgs-2019-0058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Kolset SO, Reinholt FP, Jenssen T. Diabetic nephropathy and extracellular matrix. J Histochem Cytochem 2012;60:976-86. [PMID: 23103723 DOI: 10.1369/0022155412465073] [Cited by in Crossref: 169] [Cited by in F6Publishing: 159] [Article Influence: 16.9] [Reference Citation Analysis]
25 Gholizadeh S, Visweswaran GRR, Storm G, Hennink WE, Kamps JAAM, Kok RJ. E-selectin targeted immunoliposomes for rapamycin delivery to activated endothelial cells. Int J Pharm 2018;548:759-70. [PMID: 29038064 DOI: 10.1016/j.ijpharm.2017.10.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
26 Mekahli D, Decuypere JP, Sammels E, Welkenhuyzen K, Schoeber J, Audrezet MP, Corvelyn A, Dechênes G, Ong AC, Wilmer MJ, van den Heuvel L, Bultynck G, Parys JB, Missiaen L, Levtchenko E, De Smedt H. Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin. Pflugers Arch 2014;466:1591-604. [PMID: 24193408 DOI: 10.1007/s00424-013-1394-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
27 Fernandes R, Reis F. mTOR in Diabetic Nephropathy and Retinopathy. Molecules to Medicine with mTOR. Elsevier; 2016. pp. 379-93. [DOI: 10.1016/b978-0-12-802733-2.00001-3] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Kaplan B, Qazi Y, Wellen JR. Strategies for the management of adverse events associated with mTOR inhibitors. Transplant Rev (Orlando). 2014;28:126-133. [PMID: 24685370 DOI: 10.1016/j.trre.2014.03.002] [Cited by in Crossref: 161] [Cited by in F6Publishing: 124] [Article Influence: 20.1] [Reference Citation Analysis]
29 Dong G, Liu Y, Zhang L, Huang S, Ding HF, Dong Z. mTOR contributes to ER stress and associated apoptosis in renal tubular cells. Am J Physiol Renal Physiol 2015;308:F267-74. [PMID: 25428129 DOI: 10.1152/ajprenal.00629.2014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
30 Kaeberlein M. mTOR Inhibition: From Aging to Autism and Beyond. Scientifica (Cairo) 2013;2013:849186. [PMID: 24379984 DOI: 10.1155/2013/849186] [Cited by in Crossref: 17] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
31 De Waele L, Lagae L, Mekahli D. Tuberous sclerosis complex: the past and the future. Pediatr Nephrol 2015;30:1771-80. [DOI: 10.1007/s00467-014-3027-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
32 Du C, Zhang T, Xiao X, Shi Y, Duan H, Ren Y. Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway. Biochem J 2017;474:2733-47. [PMID: 28694352 DOI: 10.1042/BCJ20170272] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
33 Lin Y, Kuro-o M, Sun Z. Genetic deficiency of anti-aging gene klotho exacerbates early nephropathy in STZ-induced diabetes in male mice. Endocrinology 2013;154:3855-63. [PMID: 23928372 DOI: 10.1210/en.2013-1053] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
34 Mok KW, Mruk DD, Cheng CY. Regulation of blood-testis barrier (BTB) dynamics during spermatogenesis via the "Yin" and "Yang" effects of mammalian target of rapamycin complex 1 (mTORC1) and mTORC2. Int Rev Cell Mol Biol 2013;301:291-358. [PMID: 23317821 DOI: 10.1016/B978-0-12-407704-1.00006-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
35 Peruchetti DB, Silva-Aguiar RP, Siqueira GM, Dias WB, Caruso-Neves C. High glucose reduces megalin-mediated albumin endocytosis in renal proximal tubule cells through protein kinase B O-GlcNAcylation. J Biol Chem 2018;293:11388-400. [PMID: 29871929 DOI: 10.1074/jbc.RA117.001337] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
36 Zhang J, Xiang X, Shu S, Zhang C, Liang Y, Jiang T, Zhang W, Guo T, Liang X, Tang X. Advanced oxidation protein products inhibit the autophagy of renal tubular epithelial cells. Exp Ther Med 2018;15:3908-16. [PMID: 29556265 DOI: 10.3892/etm.2018.5875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
37 Ma SK, Joo SY, Kim CS, Choi JS, Bae EH, Lee J, Kim SW. Increased Phosphorylation of PI3K/Akt/mTOR in the Obstructed Kidney of Rats with Unilateral Ureteral Obstruction. Chonnam Med J 2013;49:108-12. [PMID: 24400212 DOI: 10.4068/cmj.2013.49.3.108] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
38 Kitada M, Koya D. Renal protective effects of resveratrol. Oxid Med Cell Longev 2013;2013:568093. [PMID: 24379901 DOI: 10.1155/2013/568093] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 9.4] [Reference Citation Analysis]
39 Turunç V, Açıkgöz S, Dheir H. Early Switch to Mammalian Target of Rapamycin Inhibitors Is a Sustainable Treatment Approach in Renal Transplant Recipients: 7-Year Results. Transplantation Proceedings 2019;51:1070-3. [DOI: 10.1016/j.transproceed.2019.01.098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]